Sensitivity to Treatment Effects of Evaluation Instruments Completed by Psychiatrists, Psychologists, Nurses, and Patients

  • A. Raskin


There is a widespread belief that psychiatric patients make unreliable informants, especially when it comes to rating the presence and severity of their psychiatric symptoms. Hence it is felt that symptom-rating scales completed by patients are likely to be less accurate and therefore less sensitive to treatment effects than comparable scales completed by psychiatrists or psychologists [1]. (Henceforth, psychiatrist or psychologist-rated scales will be referred to as doctor-rated scales.)


Somatic Complaint Evaluation Instrument Rating Source Mood Scale Scale Sensitivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arfwidsson, L., d’Elia, G., Laurell, B., Ottossen, O., Perns, C., and Persson, G. 1974. Can self-rating replace doctor’s rating in evaluating antidepressive treatment. Acta Psychiatr. Scand. 50: 16–22.PubMedCrossRefGoogle Scholar
  2. 2.
    Blumenthal, M.D. 1975. Measuring depressive symptomatology in a general population. Arch. Gen. Psychiatry 37: 971–978.CrossRefGoogle Scholar
  3. 3.
    Burdock, E.I., Elliott, H.E., Hardesty, A.S., O’Neill, F.J., and Sklar, J. 1960. Biometric evaluation of an intensive treatment programme in a state mental hospital. J. Nerv. Ment. Dis. 130: 271–277.PubMedCrossRefGoogle Scholar
  4. 4.
    Burdock, E.I., Hardesty, A.S., Hakerem, G., and Zubin, J. A. 1960. A ward behaviour rating scale for mental patients. J. Clin. Psychol. 16: 246–247.PubMedCrossRefGoogle Scholar
  5. 5.
    Caffey, E.M., Jr., Diamond, L.S., Frank, T.V., Grasberger, J.C., Herman, L., Klett, C.J., and Rothstein, C. 1964. Discontinuation or reduction of chemotherapy in chronic schizophrenics. J. Chronic Dis. 17: 347–358.PubMedCrossRefGoogle Scholar
  6. 6.
    Carroll, B.J., Fielding, J.M., and Blashki, T.J. 1973. Depression rating scales: A critical review. Arch. Gen. Psychiatry 28: 361–366.PubMedCrossRefGoogle Scholar
  7. 7.
    Dehnel, L.L., Vestre, N.D., and Schiele, B.C. 1968. A controlled comparison of clopenthizal and perphenazine in a chronic schizophrenic population. Current Therapeutics Research 10: 169–176.Google Scholar
  8. 8.
    Fisher, S. 1976. Measurement of anxiety in outpatient trials: Detection of bias in patient and doctor ratings. Psychopharmaeol. Bull. 12: 17–18.Google Scholar
  9. 9.
    Friedhoff, A. J., and Alpert, M. 1960. The effect of chlorpromazine on the variability of motor task performance in schizophrenics. J. Nerv. Ment. Dis. 130: 110–116Google Scholar
  10. 10.
    Gernor, R. H., Catlin, O. H., Gorelick, D. A., Hui, K. K., and Li, C. H. 1980. B-Endorphin. Arch. Gen. Psychiatry 37: 642–645.CrossRefGoogle Scholar
  11. 11.
    Goldberg, H.L., Finnerty, R.J., LaBrie, R., and Rickels, K. 1978. A study of concordance between observer and patient rating scales. Psychopharmacol. Bull. 14: 7–10.PubMedGoogle Scholar
  12. 12.
    Goldberg, S.C., Klerman, G.L., and Cole, J.O. 1965. Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment. Br. J. Psychiatry 111: 120–133.PubMedCrossRefGoogle Scholar
  13. 13.
    Hall, W.B., Vestre, N.D., Schiele, B.C., and Zimmerman, R. 1968. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics. Diseases of the Nervous System 29: 405–408.PubMedGoogle Scholar
  14. 14.
    Hanlon, T.E., Nussbaum, K., Wittig, B., Hanlon, D.D., and Kurland, A. A. 1964. The comparative effectiveness of amitriptyline, perphenazine and their combination in the treatment of chronic psychotic female patients. Journal of New Drugs 4: 52–60.Google Scholar
  15. 15.
    Hamilton, M. 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23: 56–62.PubMedCrossRefGoogle Scholar
  16. 16.
    Honigfeld, G. 1974. History and current status of its use in pharmacopsychiatric research. Mod. Probl. Pharmacopsychiatry 7: 238–263.PubMedGoogle Scholar
  17. 17.
    Honigfeld, G., and Klett, C.J. 1965. The nurses’ observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia. J. Clin. Psychol. 21: 65–71.PubMedCrossRefGoogle Scholar
  18. 18.
    Honigfeld, G., Gillis, R. D., and Klett, C.J. 1966. NOSIE-30: A treatment sensitive ward behaviour scale. Psychol. Rep. 19: 180–182.PubMedCrossRefGoogle Scholar
  19. 19.
    Kellner, R. 1971. Part 1. Improvement criteria in drug trials with neurotic patients. Psychol. Med. 1: 416–425.PubMedCrossRefGoogle Scholar
  20. 20.
    Kellner, R. 1972. Part 2. Improvement criteria in drug trials with neurotic patients. Psychol. Med. 2: 73–80.PubMedCrossRefGoogle Scholar
  21. 21.
    Kellner, R., Simpson, G. M. and Sheffield, B. F. 1977. The value of self-rating scales in drug trials. Psychopharmacol. Bull. 13: 42–43.PubMedGoogle Scholar
  22. 22.
    Kellner, R., Sheffield, B. F., and Simpson, G. M. 1977. Comparative value of self-rating scales in drug trials. Psychopharmacol. Bull. 13: 12–13.PubMedGoogle Scholar
  23. 23.
    Kellner, R., Rada, R.T., Anderson, R., and Pathak, D. 1979. The effects of chlordiazepoxide on self-rated depression, anxiety and well-being. Psychopharmacology 64: 185–191.PubMedCrossRefGoogle Scholar
  24. 24.
    Kollar, E. J., Pasnav, R.O., Rubin, R.T., Naitch, P., Slater, G.G., and Kales, A. 1979. Psychological, psychophysiological, and biochemical correlates of prolonged sleep deprivation. Am. J. Psychiatry 126: 488–497.Google Scholar
  25. 25.
    Konik, D.S., Paolino, A.F., Friedman, I., and Hinko, E.M. 1967. Beer and geriatrics, an objective study. Washington Brewers Institute. Unpublished manuscript.Google Scholar
  26. 26.
    Lasky, J. J., Klett, C.J., Caffey, E.M., Bennett, J.L., Rosenblum, M.P., and Hollister, L.E. 1962. Drug treatment of schizophrenic patients. Diseases of the Nervous System 23: 698–706.Google Scholar
  27. 27.
    Lorr, M., and Vestre, N. D. 1968. Psychotic Inpatient Profile Manual. Western Psychological Services, Los Angeles.Google Scholar
  28. 28.
    McNair, D.M. 1974. Self-evaluation of antidepressants. Psychopharmacologia 37: 281–302.PubMedCrossRefGoogle Scholar
  29. 29.
    Overall, J.E., and Gorham, D.R. 1960. The brief psychiatric rating scale. Psychol. Rep. 10: 799–812.Google Scholar
  30. 30.
    Prusoff, B.A., Klerman, G.L., and Paykel, E.S. 1972. Concordance between clinical assessments and patients’ self-report in depression. Arch. Gen. Psychiatry 26: 546–552.PubMedCrossRefGoogle Scholar
  31. 31.
    Raskin, A., and Crook, T. H. 1976. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects. J. Psychiatr. Res. 13: 31–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Raskin, A., and McKeon, J.J. 1971. Super factors of psychopathology in hospitalized depressed patients. J. Psychiatr. Res. 9: 11–19.PubMedCrossRefGoogle Scholar
  33. 33.
    Raskin, A., Schulterbrandt, J., Reatig, N., and Rice, C. E. 1967. Factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depressives. J. Consult. Psychol. 31: 270–278.PubMedCrossRefGoogle Scholar
  34. 34.
    Raskin, A., Schulterbrandt, J., Reatig, N., and McKoon, J.J. 1969. Replication of factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depressives. J. Nerv. Ment. Dis. 1: 87–98.Google Scholar
  35. 35.
    Raskin, A., Schulterbrandt, J.G., Reatig, N., and McKeon, J.J. 1970. Difference response to chlorpromazine, imipramine and placebo. Arch. Gen. Psychiatry 23: 164–173.PubMedCrossRefGoogle Scholar
  36. 36.
    Raskin, A., Gershon, S., Crook, T.H., Sathananthan, G., and Ferris, S. 1978. The effects of hyperbaric and normobaric oxygen on cognitive impairment in the elderly. Arch. Gen. Psychiatry 35: 50–56.PubMedCrossRefGoogle Scholar
  37. 37.
    Snaith, P. 1981. Rating scales. Br. J. Psychiatry 138: 512–514.PubMedCrossRefGoogle Scholar
  38. 38.
    Spielberger, C.D., Gorsuch, R.L., and Lushene, R. 1968. Self-evaluation questionnaire. Consulting Psychologists Press, Palo Alto.Google Scholar
  39. 39.
    Stoffelmayr, B. E. 1973. The relationship between nurses’ ratings of patient behaviour and observed patient behaviour. Soc. Psychiatry 8: 37–40.CrossRefGoogle Scholar
  40. 40.
    Uhlenhuth, E.H., Glass, R.M., Haberman, S.J., and Kellner, R. 1982. Relative sensitivity of clinical measures in trials of antianxiety agents. In: E. I. Burdock, A. Sudilousky, and S. Gershon (eds.), The Behaviour of Psychiatric Patients — Quantitative Techniques for Evaluation, pp. 393–410. Marcel Dekker, New York.Google Scholar
  41. 41.
    Vestre, N.D. 1966. Validity data on the Psychotic Reaction Profile. J. Consult. Psychol. 30: 84–85.CrossRefGoogle Scholar
  42. 42.
    Wolpert, A., Sheppard, C., and Merlis, J. 1967. Method for evaluation of behavioural changes in aged hospital patients during anabolic steroid therapy. J. Am. Geriatr. Soc. 15: 470–473.PubMedGoogle Scholar
  43. 43.
    Zung, W. W.K. 1965. A self-rating depression scale. Arch. Gen. Psychiatry 12: 63–70.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • A. Raskin

There are no affiliations available

Personalised recommendations